Number of Participants With Hospitalization or Mortality;Number of Persons With Lower Respiratory Tract Infection (LRTI), Defined as Resting Blood Oxygen Saturation (SpO2<93%) Level Sustained for 2 Readings 2 Hours Apart and Presence of Subjective Dyspnea or Cough;Time to Clearance of Nasal SARS-CoV-2;Time to Resolution of COVID-19 Symptom Resolution in Days

Number of Participants With Hospitalization or Mortality;Number of Persons With Lower Respiratory Tract Infection (LRTI), Defined as Resting Blood Oxygen Saturation (SpO2<93%) Level Sustained for 2 Readings 2 Hours Apart and Presence of Subjective Dyspnea or Cough;Time to Clearance of Nasal SARS-CoV-2;Time to Resolution of COVID-19 Symptom Resolution in Days

Change in upper respiratory viral shedding;COVID-19 symptom resolution rates [Lopinavir-ritonavir arm only];Incidence of hospitalization or mortality;Lower respiratory tract infection (LRTI) rates

Change in upper respiratory viral shedding;COVID-19 symptom resolution rates [Lopinavir-ritonavir arm only];Incidence of hospitalization or mortality;Lower respiratory tract infection (LRTI) rates